Pronto-Peds Insulin Study ITSB
This study will compare LY900014 to insulin lispro, both in combination with lantus.

Type of Study:
Type 1 diabetes patients who are between 1 to 17 years

Study Length:
6 months

Target Age/Sex:
1-17 years, Male and Female

Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures.

Link: ClinicalTrials.gov

Staus: Closed

Description:

The reason for this study is to compare a ultra-rapid lispro to insulin lispro (Humalog) in children and adolescents with type 1 diabetes (T1D).

This Study is Closed.